Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jennifer Swank"'
Autor:
Abida Poovathukaran Babu, Esha Sharda, Avinash Kolli, Karla Mora-Rodriguez, Catherine Boldig, Tyra Gatewood, Anand Shah, Jennifer Swank, Yolanda Pina, Edwin Peguero, Muhammad Jaffer, Sepideh Mokhtari, Neha Verma
Publikováno v:
Wednesday, April 26.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ced26c343e553d6e03dd5dc65cfb69e6
https://doi.org/10.1212/wnl.0000000000202376
https://doi.org/10.1212/wnl.0000000000202376
Autor:
Ruoyu Miao, Jennifer Swank, Dan Melzer, Steven Ludlow, Leah Clark, Molly Finger, Damon R. Reed, Mihaela Druta, Andrew S. Brohl
Publikováno v:
Cancer Immunology, Immunotherapy.
Background Immune checkpoint inhibitors (ICIs) have shown modest antitumor activity in unselected advanced sarcomas. Histology driven approach to patient selection is the current standard for off-label anti-programmed cell death 1 (PD1) immunotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7dbb65a2c4aa85d079740e1f73451459
https://doi.org/10.1007/s00262-023-03387-6
https://doi.org/10.1007/s00262-023-03387-6
Autor:
Mihaela Druta, Andrew S. Brohl, Odion Binitie, Damon R. Reed, Jennifer Swank, Victoria T. Rizk, Young-Chul Kim, Ricardo J. Gonzalez, John P. Hanna, Arash O. Naghavi, David M. Joyce
Publikováno v:
Clinical Sarcoma Research, Vol 10, Iss 1, Pp 1-10 (2020)
Clinical Sarcoma Research
Clinical Sarcoma Research
Background Soft tissue sarcomas (STS) are rare and heterogeneous tumors making chemotherapy use controversial. Our goal was to identify a subset of patients with primary STS that benefit with the addition of chemotherapy. Methods A retrospective char
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bf1e0907fc9c4c1e7ad0b94e0ee4f39
http://link.springer.com/article/10.1186/s13569-020-00132-w
http://link.springer.com/article/10.1186/s13569-020-00132-w
Autor:
Jonathan Chatzkel, Michael J. Schell, Jad Chahoud, Jingsong Zhang, Rohit Jain, Jennifer Swank, Steve Ludlow, Kristina Lombardi, Yesenia Lucas, Cortlin Croft, Jennifer Rembisz, Gigi Jameel, Mayer Fishman
Publikováno v:
Clinical genitourinary cancer. 20(3)
The ligation of the interleukin-2 (IL-2) receptor and immune checkpoint blockade may each alter lymphocytes, thereby inducing regression in various cancers. Single agent objective response rates of 14% to 25% have been reported for usual schedule 14-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1c33cb5fbdf66c4bf128bce2e191ca4
https://pubmed.ncbi.nlm.nih.gov/35249821
https://pubmed.ncbi.nlm.nih.gov/35249821
Autor:
Tina Terraciano, Jonathan Alexander Chatzkel, Michael J. Schell, Jingsong Zhang, Steven Ludlow, Elaine Johnson, Cortlin Croft, Kristina Lombardi, Yesenia Artigas, Mayer Fishman, Jiqiang Yao, Sarah Hart, Yazmin Rodriguez, Jennifer Rembisz, Jennifer Swank
Publikováno v:
Journal of Clinical Oncology. 37:657-657
657 Background: Ligation of IL-2 receptor or blockade of PD-1 receptor may change lymphocytes to induce regression of cancers with diverse histology or site of origin. Single agent objective response rates of 14-25% have been reported for IL-2 therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cee95f01b2bfd688b954348d737c25bc
https://doi.org/10.1200/jco.2019.37.7_suppl.657
https://doi.org/10.1200/jco.2019.37.7_suppl.657
Autor:
William M. Atkins, John J. Hill, Jennifer Swank, Kent L. Kunze, Nina Isoherranen, Josh T. Pearson
Publikováno v:
Biochemistry. 45(20)
The heme-containing cytochrome P450s (CYPs) are a major enzymatic determinant of drug clearance and drug-drug interactions. The CYP3A4 isoform is inhibited by antifungal imidazoles or triazoles, which form low-spin heme iron complexes via formation o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::393af3455f6542aaa3b6f3080383542b
https://pubmed.ncbi.nlm.nih.gov/16700545
https://pubmed.ncbi.nlm.nih.gov/16700545